Previous studies have shown that VCAM-1 is a surface protein that may link lipotoxicity with endothelial dysfunction in MASLD by promoting cellular adhesion and infiltration of monocytes34. Here, VCAM1 is linked to metabolic dysfunction-associated steatotic liver disease.